Roche Holding AG (ETR:RHO)

Market Cap	282.50B
Revenue (ttm)	67.98B
Net Income (ttm)	10.10B
Shares Out	n/a
EPS (ttm)	12.57
PE Ratio	27.98
Forward PE	16.21
Dividend	9.70 (2.78%)
Ex-Dividend Date	Mar 27, 2025

Volume	534
Average Volume	641
Open	342.60
Previous Close	343.20
Day's Range	341.80 - 344.00
52-Week Range	272.60 - 351.80
Beta	n/a
RSI	65.66
Earnings Date	Jan 29, 2026

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1896
• Employees: 103,249
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: RHO

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF